argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
24 jun 2022 - 07:10
Statutory name
argenx SE
Title
argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europe
Date last update: 08 July 2026